Clinical Trials Browser

Phase 1 × INDUSTRY × volociximab × Clear all

NCT00654758 2017-11-21

A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 1 Completed

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00666692 2012-04-27

A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 1 Completed

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms